Recombinant Human TKTL1 Protein，His & GST

TKTL1 (transketolase-like 1) is an enzyme that plays a critical role in the non-oxidative phase of the pentose phosphate pathway, which is essential for cellular metabolism and biosynthesis of nucleotides and amino acids. This enzyme has gained significant attention in recent years due to its upregulation in various types of cancer, suggesting that it may contribute to the metabolic reprogramming associated with tumor growth and survival. Elevated TKTL1 expression has been linked to increased cell proliferation and resistance to apoptosis, thus making it a potential biomarker for cancer diagnosis and prognosis. Researchers have been focusing on the recombinant production of TKTL1 protein to better understand its structure, function, and implications in cancer metabolism. By producing TKTL1 as a recombinant protein, scientists can elucidate its enzymatic characteristics and interactions with other metabolic pathways, allowing for the development of targeted therapeutic strategies. Additionally, studying the recombinant TKTL1 offers insights into its potential role in metabolic disorders beyond cancer, highlighting its significance in pathology and as a possible target for drug development. Through functional assays, structural analysis, and interaction studies, research on TKTL1 may pave the way for novel interventions that could inhibit tumor growth by disrupting its metabolic dependencies. This burgeoning field underscores the importance of TKTL1 in cancer research and its potential as a target for innovative therapeutic approaches.